Status: Recruiting
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System
The objective of this Investigational Device Exemption trial is to confirm the safety and performance of the LivIQ leadless pacemaker system, in patients with a Class I or II indication for ventricular pacing (VVI/VDD) according to applicable guidelines. An integrated atrioventricular synchrony sub-study (AVS) is specifically designed to evaluate the AVS performance of the LivIQ system.
Participants needed: 325
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Biotronik, Inc.Updated: Jun 18, 2026Locations: 13
Eligibility criteria
Class I or Class II indication for ventricular pacing (VVI/VDD) according to app... [+3]
AV block with a ventricular escape rhythm ≤ 30 bpm at time of consent Note: Rest... [+19]